Hear + Now: Patient Perspectives on Treatment Fatigue

While healthcare providers understand the clinical mechanisms of psoriatic arthritis (PsA) treatments, a significant gap often remains between brief clinic visits and the daily, exhausting trial-and-error process patients manage at home. Data from the Psoriatic Arthritis In America survey highlights this heavy emotional toll.

Listen to this brief audio digest to discover how measuring a patient's emotional fatigue alongside physical markers can foster deeper clinical trust and optimize outcomes for individuals navigating psoriatic arthritis long-term therapy.

This audio digest was generated with the assistance of an AI tool and reviewed by a member of our Editorial Team and Health Union Medical Review Board. This information is provided for general knowledge and is not a substitute for professional medical advice.

Transcript:

Speaker 1: Today we're talking about psoriatic arthritis and the psychological and physical burden of long-term therapy for patients.

Speaker 2: So if you are a healthcare provider listening to this, you obviously know the clinical mechanisms of these therapies inside and out... But you know we really want to bridge that gap between what you see during a brief clinic visit and the daily trial-and-error process your patients manage the minute they leave your office.

Speaker 1: Yeah, and that process can be exhausting for patients. And it makes you wonder if standard clinical assessments sometimes miss the heavy mental toll patients endure, as they try to find a medication that works without severe side effects.

Speaker 2: Right. In a clinical setting, you know, the focus is naturally on joint counts and physical markers.

Speaker 1: Which makes sense, of course.

Speaker 1: It does. But finding a stable, effective treatment for psoriatic arthritis requires a lengthy trial and error process for the patient. Data from the 2025 Psoriatic Arthritis In America survey shows just how difficult it is for patients to find a treatment that works long-term. This challenge can be exhausting emotionally for patients. 32% of patients said they plan to speak to their doctor about changing or adding to their treatment plan within the next six months.

Speaker 1: Interesting. And a provider may only have about 15 minutes per visit. Is the standard clinical setup simply not designed to measure a patient's emotional exhaustion?

Speaker 2: The clinical setup is primarily designed to evaluate physical disease activity. Not necessarily the daily mental stamina required to adhere to these regimens. Because finding lasting relief is so difficult, and because those clinic visits are so brief, patients are actively taking on the burden of research at home. 73% of patients actively seek out information on psoriatic arthritis treatments and options.

Speaker 1: 73%. So it sounds like doctors give them a treatment plan and then patients inadvertently take on a second job of monitoring efficacy and side effects on their own. Is that why the data shows them leaning so heavily on patient communities?

Speaker 2: Yeah, that is exactly why they are looking for lived experiences that clinical data just does not always provide. 42% of patients said they specifically look for information regarding other patients experiences.

Speaker 1: So they want to know what it is actually like for a real person.

Speaker 2: Right. They rely on peers to see what has actually worked during this exact trial and error process because they want to know how a treatment feels on a daily basis.

Speaker 1: That need for peer validation makes sense when you look at the anxiety surrounding new therapies. We have a direct quote from a patient that illustrates this. They said, quote, "I have a bad reaction to everything I try. I am scared to try the next medicine."

Speaker 2: That makes sense. And for patients, it's not just fear of trying a new medicine. Patients are also worried about the broader impacts of the disease itself.

Speaker 1: The long-term complications, you mean?

Speaker 2: Yeah, exactly. The data supports this high level of concern. Seventy percent of patients seek information on conditions or complications related to psoriatic arthritis. And when a patient is highly anxious about potential complications, well, that psychological weight can affect how they perceive their current pain.

Speaker 1: Right. It's hard to effectively manage physical joint health if a patient is entirely overwhelmed by the fear of disease progression or the dread of trying yet another medication. So how do providers reconcile that?

Speaker 2: It requires recognizing that managing psoriatic arthritis and finding the right treatment is an exhausting process for the patient. It means addressing the emotional fatigue patients feel right alongside their joint health.

Speaker 1: Taking a more holistic view of the visit.

Speaker 2: Exactly. Providers who acknowledge this dual burden can build more trust and better equip their patients for the realities of long term therapy.

Speaker 1: We will leave you with this thought to consider for your own practice: How might your treatment outcome shift if you routinely measured a patient's emotional fatigue alongside their physical joint assessment?